Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Clinical trial NCT04355806 · UNKNOWN

Trial details

NCT number: NCT04355806
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: UNKNOWN
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Influenza Vaccine

Start date: 2020-06-01
Primary completion: 2022-12-31
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.